BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38715706)

  • 1. Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
    Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
    Front Mol Biosci; 2024; 11():1413164. PubMed ID: 38715706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer.
    Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
    Front Mol Biosci; 2021; 8():668534. PubMed ID: 34179081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
    Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
    Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Evaluation of
    Peixoto A; Cirnes L; Carvalho AL; Andrade MJ; Maria José Brito ; Borralho P; Coimbra N; Borralho PM; Carneiro AS; Castro L; Correia L; Dionísio MR; Faria C; Figueiredo P; Gomes A; Paixão J; Pinheiro M; Prazeres H; Ribeiro J; Salgueiro N; Schmitt FC; Silva F; Silvestre AR; Sousa AC; Almeida-Tavares J; Teixeira MR; André S; Machado JC
    Front Mol Biosci; 2024; 11():1298522. PubMed ID: 38721275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells.
    Li X; Zeng S; Ding Y; Nie Y; Yang M
    Front Mol Biosci; 2022; 9():984209. PubMed ID: 36120547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
    Zheng Y; Zhong G; Yu K; Lei K; Yang Q
    Front Oncol; 2020; 10():482. PubMed ID: 32328463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms.
    Frontiers Production Office
    Front Mol Biosci; 2020; 7():596445. PubMed ID: 33282913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
    Wang Z; Jia L; Yushu Sun ; Li C; Zhang L; Wang X; Chen H
    Front Mol Biosci; 2021; 8():727347. PubMed ID: 34527704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Immune Response in Myocardial Injury:
    Chong PY; Iqbal J; Yeong J; Aw TC; Chan KS; Chui P
    Front Mol Biosci; 2022; 9():887178. PubMed ID: 35433836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
    Thomas RG; Surendran SP; Jeong YY
    Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
    Papadaki C; Thomopoulou K; Monastirioti A; Koronakis G; Papadaki MA; Rounis K; Vamvakas L; Nikolaou C; Mavroudis D; Agelaki S
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Sestrin2 protects against hypoxic nerve injury by regulating mitophagy through SESN2/AMPK pathway.
    Pan C; Ai C; Liang L; Zhang B; Li Q; Pu L; Wang Z; Liu W; Chen Z; Liu H; Wang X
    Front Mol Biosci; 2024; 11():1392150. PubMed ID: 38645273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer.
    Frontiers Production Office
    Front Mol Biosci; 2022; 9():1094902. PubMed ID: 36533079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective.
    Guo K; Ma S
    Front Mol Biosci; 2021; 8():720653. PubMed ID: 34513926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
    Fortis SP; Vaxevanis CK; Mahaira LG; Sofopoulos M; Sotiriadou NN; Dinou A; Arnogiannaki N; Stavropoulos-Giokas C; Thanos D; Baxevanis CN; Perez SA
    Cancer Immunol Immunother; 2019 Jan; 68(1):57-70. PubMed ID: 30276443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: 6-Shogaol inhibits oxidative stress-induced rat vascular smooth muscle cell apoptosis by regulating OXR1-p53 axis.
    Liu J; Li B; Li W; Pan T; Diao Y; Wang F
    Front Mol Biosci; 2023; 10():1308875. PubMed ID: 37916191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
    Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF.
    Ma S; Xie Z; Zhang L; Yang Y; Jiang H; Ouyang X; Zhao Y; Liu Q; Xu X; Li L
    Front Mol Biosci; 2021; 8():705683. PubMed ID: 34268336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
    Fischer C; Deutsch TM; Feisst M; Rippinger N; Riedel F; Hartkopf AD; Brucker SY; Domschke C; Fremd C; Michel L; Burwinkel B; Schneeweiss A; Turchinovich A; Wallwiener M
    Arch Gynecol Obstet; 2022 Sep; 306(3):875-885. PubMed ID: 35237856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.